BSEFORTIS MALAR HOSPITALS LIMITED· Healthcare ServicesHighNeutral
Announced Tue, 4 Aug, 2026 · 14:38 IST

Q1FY27 results: company has no active business after slump sale

Going ConcernEmphasis Of MatterRevenue DeclineResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹50.49
prior close
₹50.80
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.2% vs market
Hospital peers, median of 26sector+0.3%-2.1% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.5
10m
+0.3
15m
+0.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.7+0.4-2.2+0.3-2.1
Next day
-0.4+1.7-2.1+0.8-1.2
2d
-1.1+2.1-3.2+1.2-2.3
3d
-2.6+2.1-4.8+1.4-4.0
4d
-2.0+2.1-4.0+1.3-3.3
5d
-2.4+1.9-4.2-0.5-1.8
1w
-2.2+2.4-4.6-1.9-0.3
15d
-6.3+3.0-9.3-1.1-5.2
1m
-10.4+3.7-14.1-2.9-7.5
2m
-20.7+1.6-22.3-8.9-11.9
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited standalone and consolidated results for quarter ended June 30, 2026. Auditor BSR and Co gave an unmodified limited review but drew attention to Note 5: the company sold its Malar Hospital business to MGM Healthcare in FY24 and now has no operations. Management is evaluating corporate restructuring options. Cash and bank balances stand at about Rs 3,458.92 lakhs, deemed sufficient to meet obligations. Pending tax and medico legal cases total about Rs 1,125 lakhs in claims.

Likely market impact

Company is a cash shell with no revenue. Stock hinges on upcoming restructuring decision and deployment of surplus cash.